※ PTMD 2.0 database Online Browse Options
Browse result for Colon cancer/carcinoma
※ introduction Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine). Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, abdominal pain and fatigue. Most colorectal cancers are due to old age and lifestyle factors, with only a small number of cases due to underlying genetic disorders. Risk factors include diet, obesity, smoking, and lack of physical activity. Dietary factors that increase the risk include red meat, processed meat, and alcohol. Another risk factor is inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis. Some of the inherited genetic disorders that can cause colorectal cancer include familial adenomatous polyposis and hereditary non-polyposis colon cancer; however, these represent less than 5% of cases. It typically starts as a benign tumor, often in the form of a polyp, which over time becomes cancerous.
Colorectal cancer may be diagnosed by obtaining a sample of the colon during a sigmoidoscopy or colonoscopy. This is then followed by medical imaging to determine whether the disease has spread. Screening is effective for preventing and decreasing deaths from colorectal cancer. Screening, by one of a number of methods, is recommended starting from the age of 45 to 75. It was recommended starting at age 50 but it was changed to 45 due to increasing amount of colon cancers. During colonoscopy, small polyps may be removed if found. If a large polyp or tumor is found, a biopsy may be performed to check if it is cancerous. Aspirin and other non-steroidal anti-inflammatory drugs decrease the risk of pain during polyp excision. Their general use is not recommended for this purpose, however, due to side effects.
Treatments used for colorectal cancer may include some combination of surgery, radiation therapy, chemotherapy, and targeted therapy. Cancers that are confined within the wall of the colon may be curable with surgery, while cancer that has spread widely is usually not curable, with management being directed towards improving quality of life and symptoms. The five-year survival rate in the United States was around 65% in 2014. The individual likelihood of survival depends on how advanced the cancer is, whether or not all the cancer can be removed with surgery, and the person's overall health. Globally, colorectal cancer is the third most common type of cancer, making up about 10% of all cases. In 2018, there were 1.09 million new cases and 551,000 deaths from the disease. It is more common in developed countries, where more than 65% of cases are found. It is less common in women than men.
Reference
Wiki: Colon cancer/carcinoma
Reference
Wiki: Colon cancer/carcinoma
| PTMD ID | UniProt Accession | Entrez ID | Gene Name | Protein Name | Organism |
|---|---|---|---|---|---|
| PTMD00477 | O75365 | 11156 | PTP4A3 | Protein tyrosine phosphatase type IVA 3 | Homo sapiens |
| PTMD00525 | P10415 | 596 | BCL2 | Apoptosis regulator Bcl-2 | Homo sapiens |
| PTMD00546 | P17844 | 1655 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | Homo sapiens |
| PTMD00894 | P16591 | 2241 | FER | Tyrosine-protein kinase Fer | Homo sapiens |
| PTMD00589 | P37231 | 5468 | PPARG | Peroxisome proliferator-activated receptor gamma | Homo sapiens |
| PTMD00927 | Q7L5N1 | 10980 | COPS6 | COP9 signalosome complex subunit 6 | Homo sapiens |
| PTMD00932 | Q96S44 | 11285 | TP53RK | EKC/KEOPS complex subunit TP53RK | Homo sapiens |
| PTMD00160 | Q04206 | 5970 | RELA | Transcription factor p65 | Homo sapiens |
| PTMD00040 | P40763 | 6774 | STAT3 | Signal transducer and activator of transcription 3 | Homo sapiens |
| PTMD00065 | P28482 | 5594 | MAPK1 | Mitogen-activated protein kinase 1 | Homo sapiens |
| PTMD00058 | P27361 | 5595 | MAPK3 | Mitogen-activated protein kinase 3 | Homo sapiens |
| PTMD00962 | P29323 | 2048 | EPHB2 | Ephrin type-B receptor 2 [Cleaved into: EphB2/CTF1; EphB2/CTF2] | Homo sapiens |
| PTMD00961 | P21709 | 2041 | EPHA1 | Ephrin type-A receptor 1 | Homo sapiens |
| PTMD00522 | P0DMV8 | 33033 | HSPA1A | Heat shock 70 kDa protein 1A | Homo sapiens |
| PTMD00297 | P19838 | 4790 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] | Homo sapiens |
| PTMD00267 | P49023 | 5829 | PXN | Paxillin | Homo sapiens |
| PTMD00621 | P56945 | 9564 | BCAR1 | Breast cancer anti-estrogen resistance protein 1 | Homo sapiens |
| PTMD00225 | P68431 | 83508 | H3C1 | Histone H3.1 | Homo sapiens |
| PTMD00192 | Q01094 | 1869 | E2F1 | Transcription factor E2F1 | Homo sapiens |
| PTMD00333 | Q15717 | 1994 | ELAVL1 | ELAV-like protein 1 | Homo sapiens |
| PTMD00707 | Q16875 | 5209 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 [Includes: 6-phosphofructo-2-kinase ; Fructose-2,6-bisphosphatase ] | Homo sapiens |
| PTMD00975 | P35240 | 4771 | NF2 | Merlin | Homo sapiens |
| PTMD00761 | Q92905 | 10987 | COPS5 | COP9 signalosome complex subunit 5 | Homo sapiens |
| PTMD00055 | P04792 | 3315 | HSPB1 | Heat shock protein beta-1 | Homo sapiens |
| PTMD00703 | Q16555 | 1808 | DPYSL2 | Dihydropyrimidinase-related protein 2 | Homo sapiens |
| PTMD00075 | P06400 | 5925 | RB1 | Retinoblastoma-associated protein | Homo sapiens |
| PTMD00202 | P08581 | 4233 | MET | Hepatocyte growth factor receptor | Homo sapiens |
| PTMD00067 | P00533 | 1956 | EGFR | Epidermal growth factor receptor | Homo sapiens |
| PTMD00043 | P04626 | 2064 | ERBB2 | Receptor tyrosine-protein kinase erbB-2 | Homo sapiens |
| PTMD00945 | Q16539 | 1432 | MAPK14 | Mitogen-activated protein kinase 14 | Homo sapiens |
| PTMD00341 | P08174 | 1604 | CD55 | Complement decay-accelerating factor | Homo sapiens |
| PTMD00645 | Q02750 | 5604 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens |
| PTMD00049 | P31749 | 207 | AKT1 | RAC-alpha serine/threonine-protein kinase | Homo sapiens |
| PTMD00459 | O14926 | 25794 | FSCN2 | Fascin-2 | Homo sapiens |
| PTMD01034 | O15519 | 8837 | CFLAR | CASP8 and FADD-like apoptosis regulator [Cleaved into: CASP8 and FADD-like apoptosis regulator subunit p43; CASP8 and FADD-like apoptosis regulator subunit p12] | Homo sapiens |
| PTMD00021 | P12931 | 6714 | SRC | Proto-oncogene tyrosine-protein kinase Src | Homo sapiens |
| PTMD00323 | P15407 | 8061 | FOSL1 | Fos-related antigen 1 | Homo sapiens |
| PTMD00551 | P19419 | 2002 | ELK1 | ETS domain-containing protein Elk-1 | Homo sapiens |
| PTMD00599 | P45985 | 6416 | MAP2K4 | Dual specificity mitogen-activated protein kinase kinase 4 | Homo sapiens |
| PTMD00649 | Q03135 | 857 | CAV1 | Caveolin-1 | Homo sapiens |
| PTMD00210 | Q05397 | 5747 | PTK2 | Focal adhesion kinase 1 | Homo sapiens |
| PTMD00237 | Q13131 | 5562 | PRKAA1 | 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Homo sapiens |
| PTMD00689 | Q14790 | 841 | CASP8 | Caspase-8 [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10] | Homo sapiens |
| PTMD01881 | Q9BVI0 | 51230 | PHF20 | PHD finger protein 20 | Homo sapiens |
| PTMD01923 | Q9UHH9 | 51447 | IP6K2 | Inositol hexakisphosphate kinase 2 -uptake stimulator) | Homo sapiens |
| PTMD01058 | P05787 | 3856 | KRT8 | Keratin, type II cytoskeletal 8 | Homo sapiens |
| PTMD01064 | P09493 | 7168 | TPM1 | Tropomyosin alpha-1 chain | Homo sapiens |
| PTMD01067 | P11387 | 7150 | TOP1 | DNA topoisomerase 1 | Homo sapiens |
| PTMD01098 | P48357 | 3953 | LEPR | Leptin receptor | Homo sapiens |
| PTMD01103 | P52565 | 396 | ARHGDIA | Rho GDP-dissociation inhibitor 1 | Homo sapiens |
| PTMD01110 | P63279 | 7329 | UBE2I | SUMO-conjugating enzyme UBC9 | Homo sapiens |
| PTMD01124 | Q13163 | 5607 | MAP2K5 | Dual specificity mitogen-activated protein kinase kinase 5 | Homo sapiens |
| PTMD01256 | Q6U949 | IGF2-AS | Putative insulin-like growth factor 2 antisense gene protein | Homo sapiens | |
| PTMD01328 | Q12983 | 664 | BNIP3 | BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 | Homo sapiens |
| PTMD01272 | P07858 | 1508 | CTSB | Cathepsin B [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain] | Homo sapiens |
| PTMD01201 | P23458 | 3716 | JAK1 | Tyrosine-protein kinase JAK1 | Homo sapiens |
| PTMD01332 | O95715 | 9547 | CXCL14 | C-X-C motif chemokine 14 | Homo sapiens |
| PTMD01310 | P39687 | 8125 | ANP32A | Acidic leucine-rich nuclear phosphoprotein 32 family member A | Homo sapiens |
| PTMD01219 | Q04912 | 4486 | MST1R | Macrophage-stimulating protein receptor [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] | Homo sapiens |
| PTMD01238 | P0C0S8 | 83298 | H2AC11 | Histone H2A type 1 | Homo sapiens |
| PTMD01244 | P67775 | 5515 | PPP2CA | Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | Homo sapiens |
| PTMD01165 | Q96GD4 | 9212 | AURKB | Aurora kinase B | Homo sapiens |
| PTMD01926 | Q9UKE5 | 23043 | TNIK | TRAF2 and NCK-interacting protein kinase | Homo sapiens |
| PTMD00974 | P01108 | 17869 | Myc | Myc proto-oncogene protein | Mus musculus |
| PTMD01158 | Q8VI36 | 19303 | Pxn | Paxillin | Mus musculus |
| PTMD01227 | P26233 | ctnnb1 | Catenin beta-1 | Xenopus laevis |
